Is Dynavax Technologies Stock a Good Investment?
Dynavax Technologies Investment Advice | DVAX |
- Examine Dynavax Technologies' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Dynavax Technologies' leadership team and their track record. Good management can help Dynavax Technologies navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Dynavax Technologies' business and its evolving consumer preferences.
- Compare Dynavax Technologies' performance and market position to its competitors. Analyze how Dynavax Technologies is positioned in terms of product offerings, innovation, and market share.
- Check if Dynavax Technologies pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Dynavax Technologies' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Dynavax Technologies stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Dynavax Technologies is a good investment.
Sell | Buy |
Strong Buy
Market Performance | OK | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Dynavax Technologies Stock
Researching Dynavax Technologies' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 100.0% of the company shares are held by institutions such as insurance companies. The book value of Dynavax Technologies was currently reported as 4.76. The company had not issued any dividends in recent years. Dynavax Technologies had 1:10 split on the 10th of November 2014.
To determine if Dynavax Technologies is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Dynavax Technologies' research are outlined below:
| Over 100.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from zacks.com: Alnylam Gets FDA Nod for Expanded Use of Amvuttra in Cardiomyopathy |
Dynavax Technologies Quarterly Liabilities And Stockholders Equity |
|
Dynavax Technologies uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Dynavax Technologies. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Dynavax Technologies' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 7th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Dynavax Technologies' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Dynavax Technologies' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-02-20 | 2024-12-31 | 0.04 | 0.05 | 0.01 | 25 | ||
2024-02-22 | 2023-12-31 | -0.01 | 0.0016 | 0.0116 | 116 | ||
2024-08-06 | 2024-06-30 | 0.06 | 0.08 | 0.02 | 33 | ||
2021-05-06 | 2021-03-31 | -0.02 | 0.01 | 0.03 | 150 | ||
2024-05-08 | 2024-03-31 | -0.02 | -0.07 | -0.05 | 250 | ||
2023-05-02 | 2023-03-31 | -0.13 | -0.19 | -0.06 | 46 | ||
2021-08-04 | 2021-06-30 | -0.04 | 0.02 | 0.06 | 150 | ||
2016-08-05 | 2016-06-30 | -0.68 | -0.75 | -0.07 | 10 |
Dynavax Technologies Target Price Consensus
Dynavax target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Dynavax Technologies' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 5 | Strong Buy |
Most Dynavax analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Dynavax stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Dynavax Technologies, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationDynavax Technologies Target Price Projection
Dynavax Technologies' current and average target prices are 13.84 and 24.60, respectively. The current price of Dynavax Technologies is the price at which Dynavax Technologies is currently trading. On the other hand, Dynavax Technologies' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Dynavax Technologies Market Quote on 25th of March 2025
Target Price
Analyst Consensus On Dynavax Technologies Target Price
Dynavax Technologies Analyst Ratings
Dynavax Technologies' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Dynavax Technologies stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Dynavax Technologies' financials, market performance, and future outlook by experienced professionals. Dynavax Technologies' historical ratings below, therefore, can serve as a valuable tool for investors.Know Dynavax Technologies' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Dynavax Technologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Dynavax Technologies backward and forwards among themselves. Dynavax Technologies' institutional investor refers to the entity that pools money to purchase Dynavax Technologies' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Renaissance Technologies Corp | 2024-12-31 | 2.4 M | Blair William & Co | 2024-12-31 | 2.3 M | D. E. Shaw & Co Lp | 2024-12-31 | 1.9 M | Tang Capital Management Llc | 2024-12-31 | 1.9 M | Amvescap Plc. | 2024-12-31 | 1.6 M | Northern Trust Corp | 2024-12-31 | 1.5 M | Mizuho Markets Americas Llc | 2024-12-31 | 1.4 M | Fisher Asset Management, Llc | 2024-12-31 | 1.3 M | Charles Schwab Investment Management Inc | 2024-12-31 | 1.2 M | Blackrock Inc | 2024-12-31 | 21.2 M | Deep Track Capital, Lp | 2024-12-31 | 17.8 M |
Dynavax Technologies' market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.72 B.Market Cap |
|
Dynavax Technologies' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.03 | 0.03 | |
| Return On Assets | 0.03 | 0.03 | |
| Return On Equity | 0.05 | 0.05 |
Determining Dynavax Technologies' profitability involves analyzing its financial statements and using various financial metrics to determine if Dynavax Technologies is a good buy. For example, gross profit margin measures Dynavax Technologies' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Dynavax Technologies' profitability and make more informed investment decisions.
Dynavax Technologies' Earnings Breakdown by Geography
Please note, the imprecision that can be found in Dynavax Technologies' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Dynavax Technologies. Check Dynavax Technologies' Beneish M Score to see the likelihood of Dynavax Technologies' management manipulating its earnings.
Evaluate Dynavax Technologies' management efficiency
At this time, Dynavax Technologies' Return On Tangible Assets are fairly stable compared to the past year. Return On Assets is likely to rise to 0.03 in 2025, whereas Return On Capital Employed is likely to drop (0) in 2025. At this time, Dynavax Technologies' Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 21.4 M in 2025, whereas Other Assets are likely to drop slightly above 3 M in 2025. Dynavax Technologies' management efficiency ratios could be used to measure how well Dynavax Technologies manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 4.59 | 4.82 | |
| Tangible Book Value Per Share | 4.57 | 4.80 | |
| Enterprise Value Over EBITDA | 39.72 | 41.70 | |
| Price Book Value Ratio | 2.78 | 4.39 | |
| Enterprise Value Multiple | 39.72 | 41.70 | |
| Price Fair Value | 2.78 | 4.39 | |
| Enterprise Value | 356.6 M | 317 M |
Evaluating the management effectiveness of Dynavax Technologies allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Dynavax Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Beta 1.231 |
Basic technical analysis of Dynavax Stock
As of the 25th of March, Dynavax Technologies shows the Downside Deviation of 1.56, mean deviation of 1.05, and Coefficient Of Variation of 1156.03. Dynavax Technologies technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Dynavax Technologies' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Dynavax Technologies insiders, such as employees or executives, is commonly permitted as long as it does not rely on Dynavax Technologies' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Dynavax Technologies insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Dynavax Technologies' Outstanding Corporate Bonds
Dynavax Technologies issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Dynavax Technologies uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Dynavax bonds can be classified according to their maturity, which is the date when Dynavax Technologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand Dynavax Technologies' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Dynavax Technologies' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0817 | |||
| Market Risk Adjusted Performance | 0.7559 | |||
| Mean Deviation | 1.05 | |||
| Semi Deviation | 1.36 | |||
| Downside Deviation | 1.56 | |||
| Coefficient Of Variation | 1156.03 | |||
| Standard Deviation | 1.42 | |||
| Variance | 2.0 | |||
| Information Ratio | 0.1052 | |||
| Jensen Alpha | 0.1179 | |||
| Total Risk Alpha | 0.1696 | |||
| Sortino Ratio | 0.0953 | |||
| Treynor Ratio | 0.7459 | |||
| Maximum Drawdown | 7.23 | |||
| Value At Risk | (1.97) | |||
| Potential Upside | 2.36 | |||
| Downside Variance | 2.44 | |||
| Semi Variance | 1.86 | |||
| Expected Short fall | (1.11) | |||
| Skewness | (0.46) | |||
| Kurtosis | 0.9403 |
| Risk Adjusted Performance | 0.0817 | |||
| Market Risk Adjusted Performance | 0.7559 | |||
| Mean Deviation | 1.05 | |||
| Semi Deviation | 1.36 | |||
| Downside Deviation | 1.56 | |||
| Coefficient Of Variation | 1156.03 | |||
| Standard Deviation | 1.42 | |||
| Variance | 2.0 | |||
| Information Ratio | 0.1052 | |||
| Jensen Alpha | 0.1179 | |||
| Total Risk Alpha | 0.1696 | |||
| Sortino Ratio | 0.0953 | |||
| Treynor Ratio | 0.7459 | |||
| Maximum Drawdown | 7.23 | |||
| Value At Risk | (1.97) | |||
| Potential Upside | 2.36 | |||
| Downside Variance | 2.44 | |||
| Semi Variance | 1.86 | |||
| Expected Short fall | (1.11) | |||
| Skewness | (0.46) | |||
| Kurtosis | 0.9403 |
Consider Dynavax Technologies' intraday indicators
Dynavax Technologies intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Dynavax Technologies stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Dynavax Technologies Corporate Filings
F4 | 20th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 13th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 10th of March 2025 Other Reports | ViewVerify | |
F3 | 5th of February 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Dynavax Stock media impact
Far too much social signal, news, headlines, and media speculation about Dynavax Technologies that are available to investors today. That information is available publicly through Dynavax media outlets and privately through word of mouth or via Dynavax internal channels. However, regardless of the origin, that massive amount of Dynavax data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Dynavax Technologies news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Dynavax Technologies relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Dynavax Technologies' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Dynavax Technologies alpha.
Dynavax Technologies Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Dynavax Technologies can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Dynavax Technologies Historical Investor Sentiment
Investor biases related to Dynavax Technologies' public news can be used to forecast risks associated with an investment in Dynavax. The trend in average sentiment can be used to explain how an investor holding Dynavax can time the market purely based on public headlines and social activities around Dynavax Technologies. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Dynavax Technologies' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Dynavax Technologies and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Dynavax Technologies news discussions. The higher the estimate score, the more favorable the investor's outlook on Dynavax Technologies.
Dynavax Technologies Corporate Management
| David Novack | Sr. VP of Operations and Quality | Profile | |
| Eric Frings | Site VP | Profile | |
| Robert MD | Medical Development | Profile | |
| Donn Casale | Senior Officer | Profile | |
| Nicole Arndt | Sr Relations | Profile |
Additional Tools for Dynavax Stock Analysis
When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.